Blechman Foundation Lecture Series in Neuroprotection
Pittsburgh Institute for Neurodegenerative Diseases (PIND)
Neuroprotection Clinical Trials in Molecularly Defined Patient Populations: Modulation of Neurodegenerative Proteins in Frontotemporal Lobe Degeneration
Adam L. Boxer, MD, PhD
Director, AD & FTD Clinical Trials Program; Associate Professor of Neurology
University of California, San Francisco
May 11, 2016 - 12:00pm
Biomedical Science Tower 3, Room 6014